Cancer's CureGawseKSfcvbfHsDMnBphwPM7pm5eDMkzMigp1Sp1pump

Melittin's Sting: A Premature Demise

Here we observe the carcass of Cancer's Cure, a token that promised salvation but delivered only a slow, agonizing decline. With a mere $2,941 in liquidity and 99.4% concentration among its oligarchic holders, this specimen never stood a chance—a financial organism whose structural defects were evident from birth. In just nine days, it has withered into irrelevance, a cautionary tale whispered in Discord channels.